Intelligent Bio Solutions INBS
NASDAQ INBS
$1.71 +0.08 (+4.98%)
As of: Sep 30, 2026 · 1:51 PM EDT

Intelligent Bio Solutions (INBS) Total Non-Current Liabilities (2023)

Updated

Intelligent Bio Solutions (INBS) recorded Total Non-Current Liabilities of $5.67 million in fiscal Q2 2024 (quarter ended Dec 31, 2023).

Analysis

Intelligent Bio Solutions (INBS) Total Non-Current Liabilities (2023) Analysis & Trends

At the end of FY2023 (ended Jun 30, 2023), Intelligent Bio Solutions reported Total Non-Current Liabilities of $6.66 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Thermo Fisher Scientific 251.30 Bn 230.45 Bn 4.88 Bn 55.95 Bn
2 Abbott Laboratories 174.70 Bn 145.78 Bn 7.27 Bn -
3 Danaher 158.94 Bn 142.76 Bn 3.61 Bn 33.25 Bn
4 Intuitive Surgical 145.87 Bn 125.42 Bn 1.96 Bn -
5 Medtronic 111.49 Bn 77.36 Bn 6.34 Bn 40.46 Bn
6 Stryker 106.96 Bn 93.08 Bn 4.50 Bn 21.28 Bn
7 Boston Scientific 63.62 Bn 58.63 Bn 3.85 Bn 17.56 Bn
8 Edwards Lifesciences 50.80 Bn 34.92 Bn 1.35 Bn 2.57 Bn
9 Becton Dickinson 49.59 Bn 46.74 Bn 2.32 Bn 23.92 Bn
10 Intelligent Bio Solutions 2.43 Mn -11.04 Mn 536,583.00 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 5.67 Mn
Jun 30, 2023 6.66 Mn
API Access

Intelligent Bio Solutions Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=INBS&period=max&api_key=YOUR_API_KEY